Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
American Journal of Clinical Oncology|July 2, 2024
Safety and Efficacy of Trastuzumab Deruxtecan for Metastatic HER2+ and HER2-low Breast Cancer: An Updated Systematic Review and Meta-Analysis of Clinical TrialsZaheer Qureshi, Faryal Altaf, Abdur Jamil, et al.
American Journal of Clinical Oncology|June 22, 2024
Efficacy of Sacituzumab Govitecan in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Comprehensive Systematic Review and Meta-analysisZaheer Qureshi, Abdur Jamil, Eeshal Fatima, et al.
Cureus|August 6, 2020
The Potential Vaccine Component for COVID-19: A Comprehensive Review of Global Vaccine Development EffortsIsrar Khan, Zahoor Ahmed, Ayesha Sarwar, et al.
American Journal of Clinical Oncology|December 29, 2025
Dual Inhibition of HER2 and VEGF Pathways in Breast Cancer: A Meta-analysis of OutcomesZaheer Qureshi, Abdur Jamil, Kazi Samsuddoha, et al.
Annals of Medicine and Surgery (2012)|September 6, 2024
Navigating uncharted waters: assessing the impact of the COVID-19 pandemic on hematopoietic stem cell transplantation: challenges and innovationsZaheer Qureshi, Faryal Altaf, Abdur Jamil, et al.
Annals of Hematology|November 7, 2024
Efficacy and safety of teclistamab in relapsed or refractory multiple myeloma: a systematic review and meta-analysisZaheer Qureshi, Abdur Jamil, Faryal Altaf, et al.
Annals of Medicine and Surgery (2012)|November 11, 2024
Breaking boundaries: exploring recent advances in anticoagulation and thrombosis management: a comprehensive reviewZaheer Qureshi, Faryal Altaf, Abdur Jamil, et al.
American Journal of Clinical Oncology|September 9, 2024
Efficacy and Safety of Abemaciclib in Combination With Endocrine Therapy for HR+/HER2- Advanced or Metastatic Breast Cancer: A Systematic Review and Meta-AnalysisZaheer Qureshi, Abdur Jamil, Eeshal Fatima, et al.
American Journal of Clinical Oncology|October 23, 2024
Efficacy and Safety of Lenvatinib in Combination With Other Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma: A Meta-analysisAbdur Jamil, Zaheer Qureshi, Rimsha Siddique, et al.
American Journal of Clinical Oncology|June 20, 2024
Efficacy and Safety of BRCA-targeted Therapy (Polyadenosine Diphosphate-ribose Polymerase Inhibitors) in Treatment of BRCA-mutated Breast Cancer: A Systematic Review and Meta-analysisZaheer Qureshi, Abdur Jamil, Faryal Altaf, et al.
Pageof 4